[ad_1]
Status: 02/02/2021 2:28 pm
According to a study in “The Lancet” magazine, the Russian Sputnik V vaccine is 91.6 percent effective. This was the result of the test results with 20,000 volunteers. The value would be similar to that of the Moderna and BioNTech / Pfizer vaccines.
After criticizing the lack of reliable studies, Russian researchers have published more details about the Sputnik V corona vaccine. According to this, the vaccine is 91.6 percent effective.
The results were published in the medical journal “The Lancet”. The scientists spoke of “intermediate analyzes” of the important phase III test among some 20,000 volunteers. The results agree with previous information.
“Mild” side effects, such as flu-like symptoms
An efficacy of 91.6 percent means that 91.6 percent fewer illnesses per 100 test subjects occurred in the vaccinated group than in the control group. This would mean that Sputnik V would be almost as effective as Moderna and BioNTech / Pfizer’s vaccines and higher than AstraZeneca’s agent.
There were only a few cases of serious side effects with Sputnik V, but the researchers did not attribute them to the vaccine, he said. Most of the volunteers reported “mild” side effects, such as flu-like symptoms and arm pain. There were also four deaths during the study, which the scientists said were not related to vaccination. One volunteer suffered a stroke.
In Moscow’s Gum department store, people wait for their vaccinations. Sputnik V has already been approved in Russia for six months.
Image: AFP
Russia seeks to register in the EU
According to Russian researchers, Sputnik V was also tested on more than 2,000 people over the age of 60. In this group, the vaccine was “equally effective and well tolerated,” according to the study. But it is not finished yet. In total, the corona vaccine will be tested on 40,000 volunteers.
The approval in Russia took place a good six months ago. At that time there was international criticism because approval for wide population application was available, although major testing had not yet started.
The vaccine is now used in the fight against corona in more than 15 countries. Russia also aspires to register with the EU.
Previously criticized for lack of transparency
The researchers published the first details about the active ingredient in “The Lancet” in early September. Several international scientists criticized this study. Researcher Polly Roy from the London School of Hygiene and Tropical Medicine said Sputnik V had been criticized for its rapid development and lack of transparency. However, the result now available is clear. The scientific principle of vaccination has been proven, he told “The Lancet.”
Denis Logunow, from the Gamaleja Research Center for Epidemiology and Microbiology in Moscow, which developed the active ingredient, said: “To stop the Covid-19 pandemic, there must be different vaccines that are based on different mechanisms of action.” Sputnik V contributes to the diversification of vaccines.
